title: Maternal morphine alters parvalbumin immunoreactivity patterns in neonatal mouse brain.
abstract: The influence of chronic maternal morphine on the parvalbumin immunoreactive patterns in developing mouse brain was studied. Female Swiss mice were administered daily saline or morphine (30 or 60 mg/kg) for a period of 7 days before mating, gestation, and 21 days postpartum. Their pups were sacrificed on postnatal day 18 and the brains were examined histologically and immunohistochemically for parvalbumin-positive neurons. Histological observations revealed no significant changes in the cell number of the morphine-exposed neonatal forebrain, whereas the number of parvalbumin-positive neurons increased in layers II-IV of the parietal cortex I. Moreover, the number of parvalbumin-positive dendrites increased remarkably in the cingulate and parietal I cortices of the morphine-exposed neonates, indicating the region-specific increase in the PV immunoreactive profiles. These results are consistent with the key roles played by the above brain regions in the altered behavioral patterns of the maternally addicted neonates, such as impaired somatosensory and cognitive performances. The mechanism of morphine action on parvalbumin expression in neonatal mouse brain is not evident, but alterations in the expression patterns of parvalbumin in specific regions of the developing brain might be one of the cellular mechanisms by which addictive drugs modify the functional aspects of the developing CNS.
authors.affiliation: CNR Institute of Cybernetics, Arco Felice, Naples, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Maharajan
authors.forename: R
authors.initials: R
authors.lastname: Prencipe
authors.forename: P
authors.initials: P
authors.lastname: Di Francesco
authors.forename: G
authors.initials: G
authors.lastname: Paino
authors.forename: G
authors.initials: G
authors.lastname: Ravagnan
authors.forename: V
authors.initials: V
authors.lastname: Maharajan
mesh_terms: D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects / Q000254:growth & development / Q000502:physiology*; D003712:Dendrites / Q000187:drug effects / Q000502:physiology; D005260:Female; D006179:Gyrus Cinguli / Q000502:physiology; D007150:Immunohistochemistry; D007774:Lactation; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D010296:Parietal Lobe / Q000502:physiology; D010320:Parvalbumins / Q000378:metabolism*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D013003:Somatosensory Cortex / Q000502:physiology
chemical_list: D010320:Parvalbumins; D009020:Morphine